Concord Healthcare Begins Trial of AI-based Diagnosis Tool; Shares Drop 10%
MT Newswires Live
Yesterday
Concord Healthcare Group (HKG:2453) had begun the trial of its artificial intelligence-based physical examination report system at partner institutions, according to a Hong Kong bourse filing Monday.
The system is designed to generate personalized health reports based on a subject's physical examination images, tests and medical history.
Shares of the company fell nearly 10% in Monday morning trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.